Severe Crohn's Disease

Featured Article

This Phase III clinical trial will evaluate the effectiveness of Cimzia (Certolizumab Pegol) in patients who have moderate to severe Crohn's disease. Researchers are currently recruiting patients age 18 to 75 who have show intolerance or insufficient progress using other Crohn's treatments.

Read more

More information on "Severe Crohn's Disease"

From Our Experts

See more SharePosts »

From Our Sources

More on Inflammatory Bowel Disease »